Literature DB >> 28757271

Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.

Poonam Mishra1, Jeffry Florian1, Joy Peter2, Monika Vainorius3, Michael W Fried3, David R Nelson2, Debra Birnkrant1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28757271     DOI： 10.1053/j.gastro.2017.07.025

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

1.  Computable Eligibility Criteria through Ontology-driven Data Access: A Case Study of Hepatitis C Virus Trials.

Authors:  Hansi Zhang; Zhe He; Xing He; Yi Guo; David R Nelson; François Modave; Yonghui Wu; William Hogan; Mattia Prosperi; Jiang Bian
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

2.  Machine learning algorithms for predicting direct-acting antiviral treatment failure in chronic hepatitis C: An HCV-TARGET analysis.

Authors:  Haesuk Park; Wei-Hsuan Lo-Ciganic; James Huang; Yonghui Wu; Linda Henry; Joy Peter; Mark Sulkowski; David R Nelson
Journal:  Hepatology       Date:  2022-02-03       Impact factor: 17.298

3.  A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.

Authors:  Mark S Sulkowski; Juhi S Moon; Kenneth E Sherman; Giuseppe Morelli; Jama M Darling; Andrew J Muir; Mandana Khalili; Dawn A Fishbein; Federico Hinestrosa; Mitchell L Shiffman; Adrian Di Bisceglie; K Rajender Reddy; Brian Pearlman; Anna S Lok; Michael W Fried; Paul W Stewart; Joy Peter; Summer Wadsworth; Scott Kixmiller; Anquenette Sloan; Monika Vainorius; Patrick M Horne; Larry Michael; Meichen Dong; Donna M Evon; Jodi B Segal; David R Nelson
Journal:  Hepatology       Date:  2021-08-26       Impact factor: 17.425

4.  A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationale.

Authors:  Cynthia Levy; Christopher L Bowlus; Elizabeth Carey; Julie M Crawford; Karen Deane; Marlyn J Mayo; W Ray Kim; Michael W Fried
Journal:  Hepatol Commun       Date:  2018-03-23

5.  International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale.

Authors:  Katrina Abuabara; Jonathan I Silverberg; Eric L Simpson; Amy S Paller; Lawrence F Eichenfield; Robert Bissonnette; James Krueger; John E Harris; Laura Dalfonso; Stephanie E Watkins; Julie M Crawford; D Thaçi; Emma Guttman-Yassky
Journal:  BMJ Open       Date:  2020-11-27       Impact factor: 2.692

6.  Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation.

Authors:  Elizabeth C Verna; Marina Serper; Jaime Chu; Kathleen Corey; Oren K Fix; Karen Hoyt; Kimberly A Page; Rohit Loomba; Ming Li; Gregory T Everson; Michael W Fried; Guadalupe Garcia-Tsao; Norah Terrault; Anna S Lok; Raymond T Chung; K Rajender Reddy
Journal:  Hepatology       Date:  2020-11       Impact factor: 17.298
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.